Several pharma, biopharma, device and diagnostic associations threw their support behind new legislation intended to exempt FDA’s user fees from sequestration. Sen. Mark Pryor (D-AR), chairman of the Senate Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration and Related Agencies, and Sens. Roy Blunt (R-MO), Daniel Coats (R-IN), Al Franken (D-MN), and Jerry Moran (R-KS) have introduced S. 1413 to exempt future FDA user fees from sequestration. A simi...